BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 3945723)

  • 1. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M; Lespinasse F; Malaise EP
    Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F; Biscay P; Malaise EP; Guichard M
    Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response.
    Edgren M; Nishidai T; Scott OC; Révész L
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Apr; 47(4):463-74. PubMed ID: 3872859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
    Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
    Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
    Jin YZ; Ding L; Shen ZF; Cai RM; Xu LM; Yang JK; Jin XQ; Lu WQ; Xu JF
    Chin Med J (Engl); 1992 Aug; 105(8):647-50. PubMed ID: 1458967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A; Smith KA; Soranson JA; Minchinton AI; Middleton RW; Denekamp J
    Radiother Oncol; 1984 Dec; 2(4):325-32. PubMed ID: 6522642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC; Henderson BW
    J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors.
    Ono K; Komuro C; Nishidai T; Shibamoto Y; Tsutsui K; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1986 Sep; 12(9):1661-6. PubMed ID: 3759592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H
    Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR; Greaves BR; Rasberry U; Barranco SC
    Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.